{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Piperazine urea derivatives as melanocortin-4 receptor agonists", "item": "https://www.patentleaderboard.com/patent/7414057"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Piperazine urea derivatives as melanocortin-4 receptor agonists

Piperazine urea derivatives as melanocortin-4 receptor agonists

US Patent 7414057 · Granted Aug 19, 2008

Estimated economic value: $115,202,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds for treating or inhibiting recurrence of acute myeloid leukemia2024
Inhibitors of cellular metabolic processes2024
Long-acting co-agonists of the glucagon and GLP-1 receptors2022
Chromane monobactam compounds for the treatment of bacterial infections2022
Inhibitors of cellular metabolic processes2022
Biaryl monobactam compounds and methods of use thereof for the treatment of bact2022
Substituted carbapenems for the treatment of bacterial infections2021
Insulin dimer-incretin conjugates2021
Glucose responsive insulin comprising a tri-valent sugar cluster for treatment o2021
Substituted N′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,2021
Inhibitors of cellular metabolic processes2020
Insulin receptor partial agonists2020